Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Interim Management Statement

4 Aug 2010 07:00

RNS Number : 4798Q
Marston's PLC
04 August 2010
 



 

MARSTON'S PLC ("MARSTON'S")

INTERIM MANAGEMENT STATEMENT

43 weeks to 31 July 2010

4 August 2010

 

Trading

 

We remain on track to meet our expectations for the financial year and continue to see improving trends in each of our trading divisions. Recent trading has been encouraging, benefiting from good weather rather than from the World Cup.

 

In Marston's Inns and Taverns, our managed pubs division, the success of our food offers and new-build strategy continue to drive growth. Like-for-like sales for the 43 weeks to 31 July were 1.7% ahead of last year, with like-for-like food sales growth of 2.5% and like-for-like wet sales growth of 1.3%. In the second half-year this good performance has continued, with like-for-like sales in the 11 weeks to 31 July up by 2.7%. We have also achieved an estimated 0.6% increase in operating margin which we anticipate will be maintained for the rest of this financial year.

 

In Marston's Pub Company, our tenanted and leased pubs division, underlying profit trends have continued to improve with like-for-like profits estimated to be down 4.0% in the 43 weeks to 31 July. This compares favourably to the 4.5% decline reported in the Interim Results in May. Approximately 86% of the estate is let on substantive agreements, including Retail Agreements. We now have 88 pubs on Retail Agreements, with performance in line with our expectations, and we intend to have 100 pubs operating under this agreement by the end of this financial year.

 

In Marston's Beer Company, despite strong prior year comparatives, own-brewed ale volumes were in line with last year demonstrating continued out-performance compared to the UK beer market which declined by around 6%. Premium ale volumes increased by 3% in the period. We continue to lead the market in the premium cask ale and premium bottled ale segments.

 

Net debt and cashflow are in line with our expectations.

 

New-Build Development Programme

 

Our development plans are on track. We have 11 sites open, and we are currently on site in 4 locations. As a result 15 new sites will have been opened in the current financial year, and as planned we expect to open 20 new pub-restaurants in 2011.

 

Performance in the new openings to date continues to be very encouraging with the run-rate for both turnover and returns ahead of our targets as described in our Interim Results.

 

Outlook

 

Following the emergency Budget in June we remain cautious about the consequential impact on consumer confidence. However, we are encouraged by our recent trading performance. Our focus on value for money, high quality pubs and local beers combined with clearly defined strategies for each of our trading divisions place us in a strong position to meet the forthcoming challenges.

 

ENQUIRIES:

Marston's PLC

Hudson Sandler

Ralph Findlay, Chief Executive

Andrew Hayes / Kate Hough

Andrew Andrea, Finance Director

Tel: 01902 329516

Tel: 020 7796 4133

 

NOTES TO EDITORS

Marston's is a leading independent brewer and pub operator.

It has an estate of 2,159 pubs situated nationally. The estate comprises 1,671 tenanted or leased pubs, and 488 managed pubs.

It is the UK's leading brewer of premium cask and premium bottled ales, including Marston's Pedigree and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers.

Marston's employs over 12,000 people throughout England and Wales.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUOUNRRBAWRAR
Date   Source Headline
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.